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1. Introduction
Coronary heart disease (CHD) is a leading cause of 
death for both men and women in the United States. CHD 
is characterized by the formation of atherosclerosis, the 
narrowing of the arteries that supply oxygen and blood to 
the heart (Lloyd-Jones et al., 2009). While CHD is a mul-
tifactorial disease, elevated total and low density lipopro-
tein (LDL) cholesterol and decreased high density lipopro-
tein (HDL) cholesterol are perhaps the most important risk 
factors for CHD (Martin et al., 1986; Pekkanen et al., 1990). 
Plasma LDL cholesterol can be lowered with both diet 
modification and with the use of cholesterol-lowering drugs. 
Several classes of drugs can lower plasma LDL cholesterol, in-
cluding statins, bile acid sequestrants, nicotinic acid, fibrates, 
and cholesterol absorption inhibitors. Statin drugs provide 
Published in Journal of Functional Foods 1 (2009), pp. 381–386; doi: 10.1016/j.jff.2009.09.005  
Copyright © 2009 Elsevier Ltd. Used by permission.
Submitted May 28, 2009; revised September 18, 2009; accepted September 28, 2009; published online October 24, 2009.
Sorghum distillers dried grain lipid extract increases  
cholesterol excretion and decreases plasma and liver  
cholesterol concentration in hamsters
Jia Tse Hoi,1 Curtis L. Weller,2,3 Vicki L. Schlegel,3  
Susan L. Cuppett,3 Ji-Young Lee,1 and Timothy P. Carr 1
1. Department of Nutrition and Health Sciences,  
University of Nebraska–Lincoln, Lincoln, NE 68583, USA
2. Department of Biological Systems Engineering,  
University of Nebraska–Lincoln, Lincoln, NE 68583, USA
3. Department of Food Science and Technology,  
University of Nebraska–Lincoln, Lincoln, NE 68583, USA
Corresponding author — T. P. Carr, Nutrition and Health Sciences, 316 Leverton Hall, University of  
Nebraska–Lincoln, Lincoln, NE 68583, USA; tel 402 472-7940, fax 402 472-1587, email tcarr2@unl.edu 
Abstract
Grain sorghum is a rich source of phytochemicals. In this study, male hamsters were fed AIN-93M diets supplemented with 
a hexane-extractable lipid fraction from sorghum distillers dried grains with solubles (DDGS). Diets contained 0.0%, 0.5%, 
1.0%, and 5.0% (w/w) DDGS lipid extract. After 4 wk, the 5.0% DDGS lipids group had significantly lower plasma non-HDL 
cholesterol and liver esterified cholesterol concentration. Fecal neutral sterol (i.e., cholesterol) excretion was significantly 
higher in the 5.0% DDGS lipids group compared to the other treatments (66% higher compared to controls). Bile acid excre-
tion was not affected by DDGS lipid intake. Fecal cholesterol excretion was negatively correlated with liver cholesterol con-
centration (r = –0.97, P = 0.026), and liver cholesterol concentration was directly correlated with plasma total cholesterol con-
centration (r = 0.96, P = 0.041). Thus, lipid extract of sorghum DDGS exhibited cholesterol-lowering properties due, at least 
in part, to increased cholesterol excretion from the body and could provide health benefits when incorporated into human 
diets.
Keywords: cholesterol, sorghum, sterols, lipid extract, hamsters
Abbreviations: DDGS, distillers dried grains with solubles; LDL, low density lipoprotein; HDL, high density lipoprotein; 
VLDL, very low density lipoprotein; NPC1L1, Niemann-Pick C1 like 1; SRB1, scavenger receptor class B type 1; SREBP2, 
sterol regulatory element binding protein-2; HMGR, 3-hydroxy-3-methylglutaryl-CoA reductase; LDLR, low density lipo-
protein receptor; ABCA1, ATP-binding cassette transporter A1; CYP7A1, cholesterol 7-hydroxylase; GAPDH, glyceralde-
hyde-3-phosphate dehydrogenase
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effective cholesterol-lowering therapy and are widely pre-
scribed (Stein, 2003), but they are costly and can cause severe 
side effects such as elevated serum levels of liver enzymes, 
skeletal muscle abnormalities, cognitive impairment, and 
even death (Evans and Rees, 2002; Farmer, 2003). 
Food-derived alternative cholesterol-lowering agents 
include dietary fiber, soy protein, and phytosterols (Carr 
and Jesch, 2006). Phytosterols, as free sterols or esterified 
to fatty acids, can play an important role in the reduction 
of plasma cholesterol in humans (Katan et al., 2003), espe-
cially for individuals who cannot tolerate statins or other 
cholesterol-lowering drugs. A recent study in our labora-
tory indicated that whole kernel grain sorghum lipid ex-
tract reduced cholesterol absorption and plasma non-HDL 
cholesterol concentration in hamsters (Carr et al., 2005), 
which was attributed to phytosterols (and, possibly, poli-
cosanols) present in the whole kernel extract. Grain sor-
ghum is a rich source of many phytochemicals (Awika 
and Rooney, 2004), yet this abundant cereal crop has 
been largely overlooked for its health benefits (Dicko et 
al., 2006). Historical concerns raised most often regarding 
grain sorghum are its poor digestibility, low protein con-
tent and quality, deficiency of Vitamins A and E, and low 
bioavailability of zinc and iron (FAO, 1995). More current 
research has emphasized that the antioxidant properties of 
polyphenolic compounds in many sorghum varieties may 
outweigh the disadvantages and that household process-
ing techniques can overcome antinutritional properties 
(Awika and Rooney, 2004; Hotz and Gibson, 2007). 
The purpose of this research was to determine whether 
lipid extracts of sorghum distillers dried grain with solu-
bles (DDGS) had cholesterol-lowering properties similar to 
extracts of sorghum whole kernels. DDGS is a byproduct of 
the ethanol industry and is primarily used for animal feed, 
yet many of the phytochemicals present in whole kernels 
are retained in the DDGS after starch depletion (Hwang et 
al., 2004). Male Syrian hamsters were used to document the 
impact of DDGS lipid extract on plasma and liver choles-
terol, sterol and bile acid excretion, and expression of genes 
involved in sterol metabolism. 
2. Materials and methods 
2.1. Animal care 
Male F1B Syrian hamsters (Bio Breeders, Watertown, MA) 
aged 7 wk and weighing ~80 g were randomly assigned to 
treatment groups (n = 8-10/treatment) and housed individ-
ually in polycarbonate cages with sawdust bedding. Ham-
sters were kept in a 25 °C room with a 12-h light:dark cycle 
and had free access to food and water throughout the 4-wk 
feeding period. All experimental procedures were approved 
by the Institutional Animal Care and Use Committee at the 
University of Nebraska (protocol #04-12-059).
2.2. Diets
Hamsters were fed a modified AIN-93M diet supple-
mented with 0.0%, 0.5%, 1.0%, or 5.0% (w/w) lipids ex-
tracted from sorghum DDGS (Table 1). The sorghum DDGS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
was obtained in 2006 from Energy Partners (now White En-
ergy, Russell, Kansas) that processes mixed commercial 
grain sorghum hybrids for ethanol. A bench-scale extrac-
tor, as constructed by Weller et al. (2006), was used to ex-
tract the lipids from the DDGS samples.Ta 
2.3. Plasma and liver lipids
On day 28, hamsters were euthanized by CO2 asphyx-
iation. Blood was collected by cardiac puncture using 10-
mL syringes containing 10 mg ethylenediaminetetraacetic 
acid (EDTA) as an anticoagulant. Red blood cells were re-
moved by centrifugation at 1000 g for 30 m at 4 °C. Apro-
tinin (1 mg/L) and phenylmethylsulphonyl fluoride (80 
mg/L) were added to the plasma as preservatives. Plasma 
total cholesterol concentration was determined enzymati-
cally using a microplate method (Carr et al., 1993). Plasma 
HDL cholesterol concentration was measured after apoli-
poprotein B precipitation, and non-HDL cholesterol (VLDL 
+ LDL) was calculated by difference. Previous hamster 
studies in our laboratory showed that the non-HDL plasma 
fraction contains >90% LDL cholesterol (Carr et al., 2000). 
Livers were perfused with saline through the portal vein to 
eliminate residual blood before being excised. Livers were 
weighed, immediately frozen in liquid nitrogen, and stored 
at –80 °C. Aliquots of frozen liver were minced and lipids 
extracted into chloroform/methanol (2:1, v/v) (Folch et al., 
1957). Total cholesterol, free cholesterol, triacylglycerol, 
and phospholipid were quantified enzymatically (Carr et 
al., 1993), and liver esterified cholesterol was calculated as 
the difference between total and free cholesterol.
2.4. Fecal sterol analysis
Feces were collected during wk 4 for quantification of 
cholesterol-derived neutral steroids and bile acids. The fol-
lowing neutral steroids were quantified and represent fe-
cal cholesterol and its metabolites: cholesterol, coprostanol, 
dihydrocholesterol, epicoprostanol, epicholestanol, copros-
Table 1. Composition of control diet fed to hamstersble 1 -fed to 
Ingredient                                                               g/kg diet 
Cornstarcha  465.2 
Dextrinized cornstarchb  155.0 
Casein  140.0 
Sucrose  100.0 
Palm oil  30.0 
Soybean oil  10.0 
Cel1ulosec  50.0 
Cholesterol  0.5 
AIN-93 mineral mix  35.0 
AIN-93 vitamin mix  10.0 
l-Cystine  1.8 
Choline bitartrate  2.5 
a. Control diet contained 0% DDGS lipids. Treatment diets con-
tained 0.5%, 1.0%, and 5.0% DDGS lipids and were added at the 
expense of cornstarch. 
b. Dyetrose (Dyets, Bethlehem, PA). 
c. Solka-Floc (International Fibre Corporation, North Tonawanda, 
NY). 
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tanone, and cholestanone. Ground feces (~100 mg) were 
acidified by adding 0.2 mL of 0.5 mol/L HCl. Lipids were 
then extracted into chloroform/methanol (2:1, v/v) (Folch 
et al., 1957) containing 10 mg/L 5-cholestane as an in-
ternal standard. The lower phase solvent was evaporated 
and the samples saponified in 2 mL of 1 mol/L methano-
lic KOH for 1 h at 50 °C. After the addition of 2 mL deion-
ized water, the fecal steroids were extracted into 5 mL hex-
ane. The hexane was evaporated under nitrogen and the 
steroids derivatized and analyzed by gas chromatography 
as previously described (Schneider et al., 2000). Fecal bile 
acid concentration was quantified enzymatically as previ-
ously described (Schneider et al., 2000). 
2.5. Total RNA isolation and quantitative real-time PCR 
Liver samples (~0.5 g) were used for total RNA extrac-
tion using TRIzol reagent (Invitrogen, Carlsbad, CA) fol-
lowing the manufacturer’s protocol. Reverse transcrip-
tion for cDNA synthesis and quantitative real-time PCR 
analysis were performed as previously described (Park et 
al., 2008; Rasmussen et al., 2008). Primers listed in Table 2 
for the following genes were designed according to Gen-
Bank database using the Primer Express 3.0 software pro-
vided by ABI: Niemann-Pick C1 like 1 (NPC1L1), scav-
enger receptor class B type 1 (SRB1), sterol regulatory 
element binding protein-2 (SREBP2), 3-hydroxy-3- meth-
ylglutaryl-CoA reductase (HMGR), LDL receptor (LDLR), 
ATP-binding cassette transporter A1 (ABCA1), cholesterol 
7-hydroxylase (CYP7A1), and glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH).
2.6. Statistical analysis
All data are expressed as means ± SEM. Data were 
found to be normally distributed; therefore, treatment dif-
ferences were determined by one-way ANOVA, followed 
by Student-Newman-Keuls multiple comparison proce-
dure (GraphPad Prism 5, La Jolla, CA). Pearson correlation 
was used to compare fecal sterol excretion and liver choles-
terol concentration. Mean differences were considered sig-
nificant at P < 0.05.
3. Results
Hamster body weights were not significantly different 
among the treatment groups at any point during the 4 wk 
study. Hamsters continued to grow (average gain 22.7 ± 
0.5 g/4 wk) and appeared healthy throughout the study. 
In subsequent calculations in which metabolic data are nor-
malized to 100 g of body weight, we used individual body 
weights as measured on the final day of the study. 
Plasma non-HDL cholesterol concentration was signifi-
cantly lower in hamsters fed 5.0% DDGS lipids compared 
to 0.5% DDGS lipids and tended to be lower compared to 
the other groups (Table 3). Plasma HDL cholesterol was 
also significantly lower in the 5.0% DDGS lipids group 
compared to the others, which was expected since ham-
sters are considered an “HDL mammal” (Trautwein et al., 
1993). Plasma triacylglycerol concentration was not signifi-
cantly affected by the level of DDGS lipids consumed. 
Liver weights, normalized to 100 g body wt, were not 
significantly different among treatments (Table 4). Liver 
free cholesterol and esterified cholesterol concentrations 
were significantly lower in the 5.0% DDGS lipids group 
compared to hamsters fed 0.5% DDGS lipids, whereas liver 
triacylglycerol was significantly higher in the 1.0% and 
5.0% DDGS groups (Table 4). Liver phospholipid concen-
tration was not significantly affected by the level of DDGS 
lipids consumed. 
Hepatic gene expression of NPC1L1, SRB1, SREBP2, 
HMGR, LDLR, and CYP7A1 was not significantly different 
Table 2. Real-time PCR primers.
Gene Forward primer Reverse primer
NPC1L1  5’-GTGGACTGGAGGGACCACITC-3’ 5’-TGCCGTCTITGAACGTGAGA-3’ 
SRB1  5’-AAGCCTGCAGGTCTATGAAGC-3’ 5’ -AGAAACCITCATTGGGTGGGTA-3’  
ABCA1  5’-ATAGCAGGCTCCAACCCTGAC-3’ 5’ -GGTACTGAAGCATGTTTCGATGTT-3’ 
SREPB2  5’-GGCCCTGGAAGTGACTGAGA-3’ 5’ -GCATGGCTCTACAGGCATAGAA-3’ 
HMGR  5’-CGAAGGGTTTGCGGTGAT-3’ 5’ -TCTGTAGACGTGCAAATCTGCTAGT-3’ 
LDLR  5’-AGACACATGCGACAGGAATGAG-3’ 5’ -GACCCACITGCTGGCGATA-3’ 
CYP7A1  5 -GTTGGCAGGCCTCCCTAT-3’ 5’ -CTGTTCCCGGGCCTTATGT-3’ 
GAPDH  5’-CCATCTTCCAGGAGCGAGATC-3’ 5’-CATACTCGGCACCAGCATCA-3’ 
Values are means ± SEM, n = 8-10. Means in the same column having different superscripts are significantly different (P < 0.05). 
Table 3. Plasma lipid concentration of hamsters fed sorghum DDGS extract for 4 weeks. 
DDGS (%)                           Non-HDL cholesterol                                  HDL cholesterol                                                Triacylglycerol 
                                                         (mmol/L)                                                (mmol/L)                                                           (mmol/L)
0.0  1.544 ± 0.1ab  2.347 ± 0.0b  2.227 ± 0.3 
0.5  1.746 ± 0.1b  2.367 ± 0.1b  2.533 ± 0.2 
1.0  1.569 ± 0.2ab  2.160 ± 0.1b  2.403 ± 0.2 
5.0  1.076 ± 0.2a  1.708 ± 0.2a  2.499 ± 0.3 
Values are means ± SEM, n = 8–10. Means in the same column having different superscripts are significantly different (P < 0.05). 
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among treatment groups (Table 5). However, liver ABCA1 
expression was significantly higher in hamsters fed 5.0% 
DDGS lipids compared to controls and 0.5% DDGS group. 
ABCA1 expression in hamsters fed 0.5% and 1.0% DDGS 
lipids were not significantly different compared to controls.
Cholesterol excretion from the body was represented 
by both fecal bile acid and fecal neutral steroid output, ex-
pressed as μmol per day, normalized to 100 g body wt (Ta-
ble 6). Fecal total bile acids were not significantly different 
among groups; however, fecal neutral steroid output in-
creased in parallel with increased intake of DDGS lipids. 
Fecal neutral steroids accounted for the majority (>91%) of 
total sterol output. 
A strong negative correlation (r = –0.97, P = 0.026) was 
observed between fecal cholesterol excretion and liver cho-
lesterol concentration (Figure 1), suggesting a dependency 
of liver cholesterol concentration on intestinal cholesterol 
uptake. Consequently, liver cholesterol concentration was 
strongly correlated with plasma total cholesterol (r = 0.96, 
P = 0.041). 
4. Discussion
This hamster study was conducted to determine the 
influence of sorghum DDGS lipid extract on several as-
pects of cholesterol metabolism known to influence human 
health. Previous experiments showed that grain sorghum 
lipid extracted from whole kernels significantly lower 
plasma and liver cholesterol. Grain sorghum lipid extract 
appeared to exert its cholesterol-lowering effect by reduc-
ing cholesterol absorption with a concomitant increase in 
fecal sterol excretion as its primary mechanism of action 
(Carr et al., 2005). Our current findings indicate similar 
metabolic responses when hamsters were fed the lipid frac-
tion extracted from sorghum DDGS. 
Our assumption was that lipids extracted from either 
whole kernels or DDGS would consist of similar compo-
nents, and that increased cholesterol excretion (i.e., de-
creased cholesterol absorption) was most likely caused by 
 
 
 
 
 
 
 
 
 
 
 
 
plant sterols. Several studies in humans and animals have 
demonstrated the ability of dietary plant sterols to inhibit 
cholesterol absorption and reduce plasma LDL cholesterol 
concentration (Law, 2000; Katan et al., 2003; Ostlund, 2004). 
Plant sterol ester fortified foods for human consumption 
have been shown to lower LDL cholesterol levels up to 
15% compared to placebo when administrated doses of 1-3 
g/day (Katan et al., 2003). Accordingly, the National Cho-
lesterol Education Program (2002) and the American Heart 
Association (Lichtenstein et al., 2006) now recommend a 
diet that contains 2 g/d of plant sterol esters as an effective 
cholesterol-lowering therapy. We have shown that plant 
sterols reduce the amount of intestinal cholesterol uptake 
into enterocytes by their ability to disrupt the incorpora-
tion of cholesterol into micelles, thereby lowering choles-
terol absorption (Jesch and Carr, 2006). 
Cholesterol-lowering effects occurred with hamsters fed 
5.0% DDGS lipids compared to lower amounts of DDGS 
lipid intake. With regard to plasma lipid response, ham-
ster non-HDL (or LDL) cholesterol responds similarly to 
humans when presented with a dietary challenge, making 
them a useful animal model (Trautwein et al., 1993). There-
fore, significant decrease in non-HDL cholesterol in ham-
sters suggests that sorghum DDGS lipid extracts could pro-
vide health benefits to human when incorporated into a 
normal diet. 
Table 4. Liver weight and lipid concentration in hamsters fed sorghum DDGS lipid extract for 4 weeks. 
                             Liver weight                  Free cholesterol         Esterified cholesterol         Triacylglycerol                Phospholipid 
DDGS (%)     (g 100g–1 body weight)           (μmol/g)                         (μmol/g)                          (μmol/g)                        (μmol/g) 
0.0  3.27 ± 0.04  5.88 ± 0.08ab  24.04 ± 1.24b  7.06 ± 0.52a  22.38 ± 0.36 
0.5  3.42 ± 0.08  6.01 ± 0.16b  23.65 ± 1.18b  10.05 ± 1.35ab  22.52 ± 0.43 
1.0  3.30 ± 0.09  5.S9 ± 0.11ab  18.56 ± 3.42ab  13.78 ± 1.19b  20.90 ± 0.61 
5.0  3.31 ± 0.05  5.53 ± 0.12a  12.95 ± 1.81a  14.18 ± 2.73b  22.35 ± 0.44 
Values are means ± SEM, n = 8–10. Means in the same column having different superscripts are significantly different (P < 0.05). 
Table 5. Hepatic gene expression in hamsters fed sorghum DDGS lipid extract for 4 weeks. 
DDGS (%)            NPC1Ll                   SRB1                   ABCA1                 SREBP2                 HMGR                  LDLR                  CYP7A1 
0.0 1.08 ± 0.12  1.09 ± 0.12  0.85 ± 0.12ab 1.24 ± 0.06  0.83 ± 0.05  0.91 ± 0.10  1.23 ± 0.25 
0.5  0.98 ± 0.11  1.19 ± 0.06  0.77 ± 0.05a 1.39 ± 0.07  0.87 ± 0.06  0.91 ± 0.09  0.97 ± 0.31 
1.0  1.29 ± 0.35  1.24 ± 0.19  0.92 ± 1.10ab 1.52 ± 0.15  0.97 ± 0.19 1.00 ± 0.18  0.99 ± 0.30 
5.0  1.25 ± 0.23  0.92 ± 0.15  1.16 ± 0.10b  1.43 ± 0.12  0.92 ± 0.11  1.11 ± 0.10  0.71 ± 0.20 
Values are means ± SEM (n = 8–10) of relative units normalized to the housekeeping gene, GAPDH. Means in the same column having different 
superscripts are significantly different (P < 0.05). 
Table 6. Cholesterol output of hamsters fed sorghum DDGS lipid 
extract for 4 weeks. 
DDGS (%)      Bile acids           Neutral steroids             Total 
                                      (μmol day–1 100 g–1 body wt) 
0.0  0.160 ± 0.01  2.495 ± 0.10a  2.674 ± 0.11a
0.5  0.129 ± 0.01  2.996 ± 0.12b  3.154 ± 0.13b 
1.0.  0.167 ± 0.03  3.476 ± 0.18c  3.643 ± 0.19c 
5.0  0.223 ± 0.07  4.140 ± 0.18d  4.534 ± 0.08d 
Values are means ± SEM, n = 8–10. Means in the same column having 
different superscripts are significantly different (P < 0.05). 
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A significant reduction in both free and esterified cho-
lesterol in the liver was seen in the 5.0% DDGS lipid group. 
Hamsters fed 5.0% DDGS lipids exhibited a significant re-
duction compared to other groups in esterified choles-
terol concentration, with a 54% reduction compared to 
control. While the reduction of free cholesterol was signif-
icant, the magnitude of change among treatment groups 
was relatively small indicating that free cholesterol in cell 
membranes is tightly regulated due to its essential role in 
cell metabolism. The trend of increasing liver triacylglyc-
erol possibly indicates that secretion of VLDL is decreased 
(Wang et al., 2005), although this was not measured in the 
current study. Liver phospholipid is an indicator of cell 
mass and was not affect by dietary treatment. 
Fecal neutral sterol excretion was significantly higher in 
all DDGS lipid groups compared to control, with the 5.0% 
DDGS group exhibiting a 66% increase compared to con-
trols. Fecal bile acids also represent an excretory pathway 
for cholesterol, although intake of DDGS lipids did not af-
fect bile acid output or gene expression of CYP7A1. These 
observations therefore indicate that DDGS lipid extract ex-
erts its cholesterol-lowering effect primarily by promoting 
excretion of intestinal neutral sterols (i.e., cholesterol and 
its metabolites). 
Policosanols were previously reported in humans to 
lower LDL cholesterol (Varady et al., 2003), possibly by in-
hibiting cholesterol synthesis (Menendez et al., 1994, 1997). 
With the assumption that the policosanol content of lipid 
extract from sorghum DDGS was similar to lipid extract 
from whole kernels (Carr et al., 2005), and based on total 
food intake, hamsters in the present study consumed poli-
cosanols in the range of 23-230 mg d–1 kg–1 body wt. Clini-
cal studies suggest that as little as 0.07 mg d–1 kg–1 can sig-
nificantly reduce LDL cholesterol concentration (Varady et 
al., 2003). In the present study, in which 3000-times more 
policosanol was presumably consumed compared to hu-
mans on a body weight basis, no changes were observed in 
gene expression of HMGR, indicating that policosanol in-
take in hamsters probably had little impact on regulating 
plasma cholesterol levels. 
Grain sorghum contains phenolic compounds that are 
beneficial to cardiovascular health due to their ability to re-
duce inflammation, reduce LDL oxidation, improve endo-
thelial function, and inhibit platelet aggregation (Awika 
and Rooney, 2004; Arts and Hollman, 2005; Vita, 2005). Ad-
ditionally, phenolic compounds have demonstrated a mod-
est cholesterol-lowering ability in some studies (Lin et al., 
1986; Santos-Buelga and Scalbert, 2000). We did not di-
rectly test the effects of sorghum phenolic compounds, al-
though their contribution to cholesterol-lowering should 
not be underestimated. 
5. Conclusions
The current evidence suggests that sorghum DDGS 
lipid extract lowers plasma and liver cholesterol concentra-
tions similarly to grain sorghum lipid extract from whole 
kernels. Mechanisms by which this occurs are due, at least 
in part, to increased fecal neutral sterol excretion (i.e., de-
creased cholesterol absorption). Grain sorghum is a rich 
source of phytochemicals, including plant sterols; there-
fore, lipid extracts from whole kernels or DDGS could pro-
vide health benefits when incorporated into human diets. 
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